<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=882962&amp;fmt=gif">

Check Out Our Recent Interview on Sports Medicine WeeklyListen Here

Bandgrip Joins Forces With Medline

CHICAGO, April 27, 2020 /PRNewswire/ -- BandGrip, innovator of the Micro-Anchor Skin Closure, has formed an exclusive sales, marketing and distribution agreement with Medline Industries, Inc., a global manufacturer and distributor of healthcare products.

"Medline always is looking for the next innovation of patient-centered solutions, and BandGrip's unique patented micro-anchor skin closure technology is faster for surgeons to apply than traditional sutures," said Hillary Epperson, senior product manager of Advanced Skin & Wound Care for Medline. "We especially appreciate that BandGrip reduces the likelihood of additional scarring for patients with longer incisions, compared to traditional closure methods like sutures and staples."

Enhancing the post-operative patient experience

Orthopedic surgeons are expected to perform more than 6.6 million procedures in 2020. With one in seven Americans reporting an orthopedic impairment, surgeons are looking at ways to reduce closure time and improve ambulation.

BandGrip is a 3.5"x1.5" bandage that offers a non-invasive method of wound closure without the use of needles or staples. Simple and intuitive, a wide range of healthcare professionals can apply the bandage without the involvement of the orthopedic surgeon. BandGrip uses non-invasive micro-anchors that grip the skin gently and securely to pull wound edges together, and reduce wound closure time by more than 30%.

The BandGrip Micro-Anchor Skin Closure is perfectly positioned as the wound closure of choice especially for surgeons that have adopted a more integrated telemedicine protocol into their post-operative care. Unlike other wound closure techniques such as sutures and staples, patients can remove their BandGrip Micro-Anchor Skin Closure from home, possibly preventing a return visit to their physician's office or hospital in this age of social distancing.

"COVID-19 is changing our wound closure protocol, and BandGrip has the solution," said Orthopedic Sports Medicine Surgeon Brian Cole, M.D., M.B.A., managing partner at Midwest Orthopaedics at Rush and Associate Chairman and Professor, Department of Orthopedics at Rush University. "Patients are able to remove the adhesive wound closure bandage from home, a little more than a week following surgery. Through telemedicine, we're able to check-in and see how the surgical incision is healing. This has become the new standard of care in my practice." Dr. Cole, who consults and is an advisor to BandGrip, also is the head team physician for the Chicago Bulls and a co-team physician for the Chicago White Sox.

"We are thrilled to have this exclusive relationship with Medline," said Fred Smith, founder and CEO of BandGrip. "We anticipate extraordinary growth in these transformative times in healthcare. We are pleased to play a role in improved patient care, especially with telemedicine now reaching a tipping point."

The terms of the agreement between BandGrip and Medline are undisclosed.

For more information on BandGrip's wound closure technology, visit www.bandgrip.com. See the application of BandGrip by clicking here, and the removal of it by clicking here